Skip to main content
PMC home page
NeuroRx logoLink to NeuroRx
. 2012 Sep 5;3(2):181–191. doi: 10.1016/j.nurx.2006.01.002

The pharmacological treatment options for pediatric migraine: An evidence-based appraisal

Donald W Lewis 1,✉, Paul Winner 1
PMCID: PMC3593442  PMID: 16554256

Summary

The treatment of children and adolescents who suffer from migraine headaches must be individually tailored, flexible, and balanced with a blend of bio-behavioral measures, agents for acute treatment and, if needed, daily preventive medicines. While controlled data is limited, there is now enough evidence available to provide a rational framework to build treatment plans appropriate for the pediatric population. Essentially, the pharmacological management of pediatric migraine divides into agents for the acute attacks and agents used daily to prevent or reduce the frequency of attacks. For the acute treatment, the most rigorously studied agents are ibuprofen, acetaminophen, and the nasal spray forms of sumatriptan and zolmitriptan, all of which have shown both safety and efficacy in controlled trials. For preventive treatment the calcium channel blocker flunarezine has the best efficacy profile in controlled trials, but is not available in the U.S. A growing body of data, mostly uncontrolled, is emerging regarding the use of several anti-epileptic agents (e.g. topiramate, disodium valproate, levateracetam), as well as the antihistamine cyproheptadine and the anti-depressant amitriptyline.

Key Words: Migraine, treatment, children, adolescents

References

  • 1.Lewis D., Ashwal S., Hershey A., et al. Practice Parameter: Pharmacological treatment of migraine headache in children and adolescents. Neurology. 2004;63:2215–2224. doi: 10.1212/01.WNL.0000147332.41993.90. [DOI] [PubMed] [Google Scholar]
  • 2.Valquist B. Migraine in children. Internat Arch Allergy. 1955;7:348–355. doi: 10.1159/000228238. [DOI] [PubMed] [Google Scholar]
  • 3.Prensky AL, Sommer D. Diagnosis and treatment of migraine in children. Neurology. 1979;29:506–510. doi: 10.1212/WNL.29.4.506. [DOI] [PubMed] [Google Scholar]
  • 4.Oleson J. The international classification of headache disorders. Cephalalgia. 2004;24(suppl. 1):1–160. doi: 10.1111/j.1468-2982.2003.00824.x. [DOI] [PubMed] [Google Scholar]
  • 5.Silberstein SD. Practice Parameter: Evidence-based guidelines for migraine headache (an evidence-based review) Neurology. 2000;55:754–762. doi: 10.1212/WNL.55.6.754. [DOI] [PubMed] [Google Scholar]
  • 6.Powers S, Patton S, Hommell K, Hershey A. Quality of life in paediatric migraine: characterization of age-related effects using PedsQL 4.0. Cephalalgia. 2004;24:120–127. doi: 10.1111/j.1468-2982.2004.00652.x. [DOI] [PubMed] [Google Scholar]
  • 7.Hamalainen M., Hoppu K., Valkeila E., et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997;48:102–107. doi: 10.1212/wnl.48.1.103. [DOI] [PubMed] [Google Scholar]
  • 8.Lewis D., Kellstein D., Burke B, et al. Children’s ibuprofen suspension for the acute treatment of migraine headache. Headache. 2002;42:780–786. doi: 10.1046/j.1526-4610.2002.02180.x. [DOI] [PubMed] [Google Scholar]
  • 9.Hamalainen M. Sumatriptan for migraine attacks in children: A randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently that adults? Neurology. 1997;48:1100–1103. doi: 10.1212/WNL.48.4.1100. [DOI] [PubMed] [Google Scholar]
  • 10.Winner P, Prensky A, Linder S, et al. Adolescent migraine: efficacy and safety of sumatriptan tablets. Journal of Neurological Sciences. 1997;150:S172–S172. doi: 10.1016/S0022-510X(97)85694-8. [DOI] [Google Scholar]
  • 11.Winner P, Rothner AD, Saper J, et al. Sumatriptan nasal spray in the treatment of acute migraine in adolescent. Pediatrics. 2000;106:989–997. doi: 10.1542/peds.106.5.989. [DOI] [PubMed] [Google Scholar]
  • 12.Winner P, Rothner A, Webster C, Ames M. Overall efficacy of Sumatriptan Nasal Spray in Adolescent Migraineurs: Pooled Results from US Placebo-Controlled Trials. Headache. 2004;44:465–465. [Google Scholar]
  • 13.Linder SL. Subcutaneous Sumatriptan in the Clinical Setting: The first 50 consecutive patients with acute migraine in the pediatric neurology office practice. Headache. 1996;36:419–422. doi: 10.1046/j.1526-4610.1996.3607419.x. [DOI] [PubMed] [Google Scholar]
  • 14.Winner P, Lewis D, Visser WH, et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind placebo-controlled study. Headache. 2002;42:49–55. doi: 10.1046/j.1526-4610.2002.02013.x. [DOI] [PubMed] [Google Scholar]
  • 15.Linder SL, Dowson AJ. Zolmitriptan provides effective migraine relief in ado-lescents. Int J Clin Prac. 2000;54:466–469. [PubMed] [Google Scholar]
  • 16.Lewis D, Winner P, Hershey A, et al. Zolmitriptan 5 mg nasal spray is effective and well-tolerated in the acute treatment of adolescent migraine. European J of Neuro. 2005;12(Suppl 12):206–206. [Google Scholar]
  • 17.Lewis D, Diamond S, Scott D, et al. Prophylactic treatment of pediatric migraine. Headache. 2004;44:230–237. doi: 10.1111/j.1526-4610.2004.04052.x. [DOI] [PubMed] [Google Scholar]
  • 18.Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurologica. 1974;50:109–115. doi: 10.1111/j.1600-0404.1974.tb01350.x. [DOI] [PubMed] [Google Scholar]
  • 19.Forsythe WI, Gillies D, Sills MA. Propranolol (Inderal) in the treatment of childhood migraine. Dev Med Child Neuro. 1984;26:737–741. doi: 10.1111/j.1469-8749.1984.tb08166.x. [DOI] [PubMed] [Google Scholar]
  • 20.Olness K, MacDonald JT, Uden DL. Comparison of Self-Hypnosis and Propranolol in the Treatment of Juvenile Classic Migraine. Pediatrics. 1987;79:593–597. [PubMed] [Google Scholar]
  • 21.Noronha MJ. Double-blind randomized cross-over trial of timolol in migraine prophylaxis in children. Cephalalgia. 1985;5(Suppl. 3):174–175. [Google Scholar]
  • 22.Hershey AD, Powers SW, Bentti AL, deGrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache. 2000;40:539–549. doi: 10.1046/j.1526-4610.2000.00085.x. [DOI] [PubMed] [Google Scholar]
  • 23.Battistella P, Ruffilla R, Baldin L, et al. Trazodone prophylaxis of childhood migraine: A double blind placebo controlled cross-over study. Giornale di Neuropsichiatria Dell ‘Eta Evolutiva. 1993;13:179–186. [Google Scholar]
  • 24.Gillies D, Sills M, Forsythe I. Pizotifen (Sanomigran) in childhood migraine. A double-blind placebo controlled trial. 1986;25:32–35. doi: 10.1159/000115983. [DOI] [PubMed] [Google Scholar]
  • 25.Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: A double-blind, placebo-controlled study. Headache. 2001;41:968–975. doi: 10.1046/j.1526-4610.2001.01190.x. [DOI] [PubMed] [Google Scholar]
  • 26.Hershey AD, Powers SW, Vockell AL, et al. Effectiveness of topiramate in the prevention of childhood headache. Headache. 2002;42:810–818. doi: 10.1046/j.1526-4610.2002.02185.x. [DOI] [PubMed] [Google Scholar]
  • 27.Younkin DP. Topiramate in the treatment of pediatric migraine. Headache. 2002;42:456–456. [Google Scholar]
  • 28.Ferreia J, Garcia N, Pedreira L. A case series of topiramate in pediatric and adolescent migraine prophylaxis. Headache. 2002;42:453–453. [Google Scholar]
  • 29.Caruso JM, Brown WD, Exil G, Gascon GG. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache. 2000;40:672–676. doi: 10.1046/j.1526-4610.2000.040008672.x. [DOI] [PubMed] [Google Scholar]
  • 30.Serdaroglu G, Erhan E, Tekgul, et al. Sodium valproate prophylaxis in childhood migraine. Headache. 2002;42:819–822. doi: 10.1046/j.1526-4610.2002.02186.x. [DOI] [PubMed] [Google Scholar]
  • 31.Miller GS. Efficacy and safety of levetiracetam in pediatric migraine. Headache. 2004;44:238–243. doi: 10.1111/j.1526-4610.2004.04053.x. [DOI] [PubMed] [Google Scholar]
  • 32.Belman AL, Milazo M, Savatic M. Gabapentin for Migraine Prophylaxis in Children. Annals of Neurology. 2001;50(Suppl 1):S109–S109. [Google Scholar]
  • 33.Battistella PA, Ruffilli R, Moro R, Fabiani M, Bertoli S, Antolini A, Zacchello F. A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache. 1990;30:264–268. doi: 10.1111/j.1526-4610.1990.hed3005264.x. [DOI] [PubMed] [Google Scholar]
  • 34.Sorge F, Marano E. Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia. 1985;5(Suppl. 2):145–148. doi: 10.1177/03331024850050S227. [DOI] [PubMed] [Google Scholar]
  • 35.Sorge F, DeSimone R, Marano E, et al. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled crossover study. Cephalalgia. 1988;8:1–6. doi: 10.1046/j.1468-2982.1988.0801001.x. [DOI] [PubMed] [Google Scholar]
  • 36.Guidetti V, Moscato D, Ottaviano S, et al. Flunarizine and migraine in childhood an evaluation of endocrine function. Cephalalgia. 1987;7:263–266. doi: 10.1046/j.1468-2982.1987.0704263.x. [DOI] [PubMed] [Google Scholar]
  • 37.Lewis DW, Middlebrook MT, Deline C. Naproxen Sodium for Chemoprophylaxis of Adolescent Migraine. Annals of Neurology. 1994;36:542–542. [Google Scholar]
  • 38.Victor S, Ryan S. Drugs for preventing migraine headaches in children. Cochrane Database System Reviews. 2003;4:CD 002761–CD 002761. doi: 10.1002/14651858.CD002761. [DOI] [PubMed] [Google Scholar]

Articles from NeuroRx are provided here courtesy of Am. Soc. for Experimental NeuroTherapeutics

RESOURCES